Cage Bio Inc.

This study tested whether a new ointment called CGB-500, containing the drug tofacitinib, can safely improve eczema (atopic dermatitis) in people aged 12 and older. 180 participants applied the ointment or a placebo daily for 8 weeks. Researchers measured how much the skin cleare…

This study tested a new ointment called CGB-500 (tofacitinib) for treating atopic dermatitis, a common skin condition. Three people aged 12 and older applied the ointment and a comparator twice daily for four weeks. The goal was to see if it reduces skin redness and itching safel…

This study tested a gel called CGB-400 on 15 adults with toenail fungus. The goal was to see if the gel could clear the fungus and make nails look better. Participants applied the gel for up to 12 weeks, with follow-up visits to check progress.